GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » PB Ratio

D&D Pharmatech (XKRX:347850) PB Ratio : 6.22 (As of Jun. 21, 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-21), D&D Pharmatech's share price is ₩27800.00. D&D Pharmatech's Book Value per Share for the quarter that ended in Dec. 2023 was ₩4,472.98. Hence, D&D Pharmatech's PB Ratio of today is 6.22.

The historical rank and industry rank for D&D Pharmatech's PB Ratio or its related term are showing as below:

XKRX:347850' s PB Ratio Range Over the Past 10 Years
Min: 6.09   Med: 7.09   Max: 9.05
Current: 6.21

During the past 6 years, D&D Pharmatech's highest PB Ratio was 9.05. The lowest was 6.09. And the median was 7.09.

XKRX:347850's PB Ratio is ranked worse than
82% of 1300 companies
in the Biotechnology industry
Industry Median: 2.33 vs XKRX:347850: 6.21

During the past 12 months, D&D Pharmatech's average Book Value Per Share Growth Rate was 343.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -44.90% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of D&D Pharmatech was -44.90% per year. The lowest was -49.30% per year. And the median was -47.10% per year.

Back to Basics: PB Ratio


D&D Pharmatech PB Ratio Historical Data

The historical data trend for D&D Pharmatech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech PB Ratio Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - - - -

D&D Pharmatech Quarterly Data
Dec22 Sep23 Dec23
PB Ratio - - -

Competitive Comparison of D&D Pharmatech's PB Ratio

For the Biotechnology subindustry, D&D Pharmatech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D&D Pharmatech's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D&D Pharmatech's PB Ratio distribution charts can be found below:

* The bar in red indicates where D&D Pharmatech's PB Ratio falls into.



D&D Pharmatech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

D&D Pharmatech's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=27800.00/4472.98
=6.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


D&D Pharmatech  (XKRX:347850) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


D&D Pharmatech PB Ratio Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


D&D Pharmatech (XKRX:347850) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech (XKRX:347850) Headlines

No Headlines